سعر تادالاسبي 20مجم اقراص 2024

Tadalasby tadalafil 20 mg film-coated tablets, pack of 2, High Performance Pharma Egypt > Glasby Pharma (Egypt listing); a PDE5 inhibitor.

• Erectile dysfunction (as-needed use)Population: Adult menDailyMed (U.S. National Library of Medicine)

• Most common (≥2%): headache, dyspepsia, back pain, myalgia, nasal congestion, flushing and pain in limb.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Use of any form of organic nitrate, regularly or intermittently.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Known serious hypersensitivity to tadalafil.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Co-administration with guanylate cyclase stimulators such as riociguat.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Consider cardiovascular status before use; sexual activity carries cardiac risk.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Seek emergency treatment for an erection lasting more than 4 hours (priapism).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Stop and seek care for sudden loss of vision (possible NAION) or sudden decrease or loss of hearing.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Organic nitratesContraindicated: tadalafil potentiates the hypotensive effect of nitrates.DailyMed (U.S. National Library of Medicine)
• Potent CYP3A4 inhibitors (e.g. ketoconazole, ritonavir)Increase tadalafil exposure; as-needed dose should not exceed 10 mg every 72 hours.DailyMed (U.S. National Library of Medicine)
• Alpha-blockers and antihypertensivesAdditive blood-pressure lowering; start ED therapy at the lowest dose in patients stable on alpha-blockers.DailyMed (U.S. National Library of Medicine)

• Not indicated for use in females; no data in pregnant women; no adverse developmental effects in animal reproduction studies at the doses tested.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for use in females; no information on presence in human milk; present in rat milk at about 2.4 times plasma concentrations.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Tadalafil: Inhibits PDE5, increasing cGMP in corpus cavernosum and prostate/bladder smooth muscle (US CIALIS).